000 | 01060 a2200301 4500 | ||
---|---|---|---|
005 | 20250515173828.0 | ||
264 | 0 | _c20100319 | |
008 | 201003s 0 0 eng d | ||
022 | _a1365-2230 | ||
024 | 7 |
_a10.1111/j.1365-2230.2008.03151.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHussain, W | |
245 | 0 | 0 |
_aThe role of imiquimod in treating infantile haemangiomas: cause for concern? _h[electronic resource] |
260 |
_bClinical and experimental dermatology _cOct 2009 |
||
300 |
_ae257 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aAminoquinolines _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemangioma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImiquimod |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
700 | 1 | _aJudge, M R | |
773 | 0 |
_tClinical and experimental dermatology _gvol. 34 _gno. 7 _gp. e257 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2230.2008.03151.x _zAvailable from publisher's website |
999 |
_c18931884 _d18931884 |